Women's Fem Dophilus

Fem-Dophilus(R) contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1(R) and Lactobacillus reuteri, RC-14(R), discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech.

Over 25 years of research supports the oral use of GR-1(R) and RC-14(R) to colonize and promote healthy vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus(R) from stomach acid and enhances probiotic bacterial survival to the lower intestine.

04214FEM60 PROD # 103030

Jarrow Formulas(R) puts the “PRO” in probiotics(R)

(C) 2014 Jarrow FORMULAS(R)

25+ YEARS OF RESEARCH/CLINICAL STUDIES

PATENTED STRAINS LACTOBACILLUS RHAMNOSUS GR-1(R) and LACTOBACILLUS REUTERI RC-14(R)

5 Billion viable cells per capsule when kept refrigerated and within Best Used Before Date.

Suggested Use: For maintenance, take 1 capsule orally per day and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional.

Keep refrigerated.

Keep out of reach of children.

Under license from Chr. Hansen A/S and protected by Chr. Hansen A/S patents of the WO 00/35465 patent family, and others.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

VAGINAL/URINARY TRACT HEALTH

Made in Denmark by Chr. Hansen A/S

GLUTEN FREE

ORAL PROBIOTIC SUPPLEMENT

Contains: Dairy (casein, in trace amounts).

Contains: Dairy (casein, in trace amounts).

No wheat, no gluten, no soybeans, no egg, no fish/shellfish, no peanuts/tree nuts.

02514FEM60 PROD # 103030

GR-1(R)/RC-14(R) and VAGINAL FLORA In one of the randomized clinical trials, 75% of women in the GR-1(R)/RC-14(R) probiotic + antibiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (antibiotic only) group experienced similar improvement. GR-1/RC-14(R) 75% Control Group 34%

Martinez, et al. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1(R), and Lactobacillus reuteri RC-14(R) : a randomized, double-blind, placebo-controlled trial. Can J Microbiol 2009;55:133-138 {chart} 25+ YEARS OF GR-1(R)/ RC-14(R) RESEARCH / CLINICAL STUDIES Fem-Dophilus(R) Introduced (2006) 1988 1994 2000 2006 2012 2014 1988-First Research on GR-1(R)/RC-14(R) Strains Begin -27 Clinical Studies Published Between 2001 and 2014

RC-14(R) and GR-1(R) are Trademarks of Chr. Hansen A/S.